Drugs / Astragalus
Astragalus
Trials 11 · a red edge is where a trial was stopped
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01847807 Comparator | Jan 2011 → Jun 2015 | metabolic syndrome X | LanZhou University | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Astragalus | “Astragalus 60g. Oral administration, twice one day, for 12weeks.” NCT02846207 ↗ |
| Known as | Astragalus membranaceus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03911921 ↗ |
| Known as | Astragalus Membranaceus Root | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06694597 ↗ |
| Known as | Huang-Chi | “Astragalus membranaceus (AM, Huang-Chi) is a Chinese herb used extensively in China as a traditional treatment to treat stroke for a long time, and a number of studies have...” NCT03271697 ↗ |
| Known as | HuangQi | “MaZiRenWan 10g plus HuangQi 20g are chosen as the core prescription.” NCT02795390 ↗1“Qi deficiency：huangqi, dangshen” NCT01939236 ↗ |
| Action | Inhibit | “Investigators found that Astragalus can not only inhibit the growth of pancreatic tumors” NCT06234072 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Chinese Herb Astragalus membranaceus” NCT01428401 ↗ |
| Route | Oral | “drunk with warm water” NCT05506891 ↗ |